Difficulty: Medium
Average Score: 83%
Simulated
A client currently taking ipratropium (Atrovent) presents to the healthcare setting for reevaluation of his current asthma status. Which of the following statements apply to ipratropium (Atrovent)? (Select All that Apply.)
Correct answer
B,D,E,F
Rationale
The correct answers are B, D, E, and F.
B: Ipratropium blocks acetylcholine receptors in the airway, leading to bronchodilation, making it effective for asthma.
D: Clients allergic to soybean should avoid ipratropium as it may contain soy lecithin.
E: Urinary retention is a common side effect of ipratropium due to its anticholinergic effects.
F: Ipratropium is used for both asthma and COPD due to its bronchodilator effects.
A is incorrect as short-acting beta-agonists are the drug of choice for acute asthma exacerbations. C is incorrect as ipratropium does not antagonize histamine receptors.
B: Ipratropium blocks acetylcholine receptors in the airway, leading to bronchodilation, making it effective for asthma.
D: Clients allergic to soybean should avoid ipratropium as it may contain soy lecithin.
E: Urinary retention is a common side effect of ipratropium due to its anticholinergic effects.
F: Ipratropium is used for both asthma and COPD due to its bronchodilator effects.
A is incorrect as short-acting beta-agonists are the drug of choice for acute asthma exacerbations. C is incorrect as ipratropium does not antagonize histamine receptors.